You are here

  • Home
  • Archive
  • Volume 48, Issue 4
  • Telemedicine as an alternative way to access abortion in Italy and characteristics of requests during the COVID-19 pandemic

Article info

Article menu
Download PDFPDF
Original research
Telemedicine as an alternative way to access abortion in Italy and characteristics of requests during the COVID-19 pandemic

Authors

  • Karin Brandell Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden Sodertalje Hospital, Sodertalje, Sweden PubMed articlesGoogle scholar articles
  • Hannah Vanbenschoten Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden Department of Bioengineering, University of Washington, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Mirella Parachini AMICA (Associazione Medici Italiani Contraccezione e Aborto), Rome, Italy International Federation of Abortion and Contraception Professionals, Vienna, Austria PubMed articlesGoogle scholar articles
  • Rebecca Gomperts Women on Web, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Kristina Gemzell-Danielsson Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden Gynecology and Reproductive Medicine, Karolinska Universitetssjukhuset, Stockholm, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Karin Brandell, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden; karin.brandell{at}ki.se
View Full Text

Citation

Brandell K, Vanbenschoten H, Parachini M, et al
Telemedicine as an alternative way to access abortion in Italy and characteristics of requests during the COVID-19 pandemic
BMJ Sexual & Reproductive Health 2022;48:252-258.

Publication history

  • Received July 19, 2021
  • Accepted October 6, 2021
  • First published October 25, 2021.
Online issue publication 
November 16, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage